California Public Employees Retirement System Vertex Pharmaceuticals Inc Transaction History

California Public Employees Retirement System

  • $147 Billion
  • Q4 2024

A detailed history of California Public Employees Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, California Public Employees Retirement System holds 880,214 shares of VRTX stock, worth $430 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
880,214
Previous 967,851 9.05%
Holding current value
$430 Million
Previous $450 Million 21.25%
% of portfolio
0.24%
Previous 0.32%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$396.64 - $516.74 $34.8 Million - $45.3 Million
-87,637 Reduced 9.05%
880,214 $354 Million
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $20.3 Million - $22.4 Million
-44,207 Reduced 4.37%
967,851 $450 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $66.1 Million - $81.7 Million
-168,295 Reduced 14.26%
1,012,058 $474 Million
Q1 2024

Apr 30, 2024
SELL
$407.69 - $446.08 $137 Million - $150 Million
-335,463 Reduced 22.13%
1,180,353 $493 Million
Q4 2023

Feb 01, 2024
BUY
$343.0 - $410.68 $2.01 Million - $2.4 Million
5,855 Added 0.39%
1,515,816 $617 Million
Q3 2023

Nov 02, 2023
BUY
$338.18 - $362.46 $14.3 Million - $15.3 Million
42,343 Added 2.89%
1,509,961 $525 Million
Q2 2023

Aug 09, 2023
SELL
$314.42 - $351.91 $3.81 Million - $4.27 Million
-12,127 Reduced 0.82%
1,467,618 $516 Million
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $19.3 Million - $22.1 Million
-68,292 Reduced 4.41%
1,479,745 $466 Million
Q4 2022

Feb 08, 2023
SELL
$285.76 - $321.48 $72 Million - $81 Million
-251,831 Reduced 13.99%
1,548,037 $447 Million
Q3 2022

Nov 09, 2022
SELL
$273.83 - $305.53 $21.1 Million - $23.6 Million
-77,220 Reduced 4.11%
1,799,868 $521 Million
Q2 2022

Aug 10, 2022
SELL
$234.96 - $292.55 $5.98 Million - $7.45 Million
-25,463 Reduced 1.34%
1,877,088 $529 Million
Q1 2022

May 04, 2022
SELL
$221.42 - $260.97 $8.03 Million - $9.46 Million
-36,268 Reduced 1.87%
1,902,551 $497 Million
Q4 2021

Feb 10, 2022
SELL
$177.01 - $223.45 $11.9 Million - $15.1 Million
-67,499 Reduced 3.36%
1,938,819 $426 Million
Q3 2021

Nov 10, 2021
BUY
$181.39 - $202.99 $2.16 Million - $2.42 Million
11,900 Added 0.6%
2,006,318 $364 Million
Q2 2021

Aug 13, 2021
SELL
$187.49 - $221.1 $2.72 Million - $3.2 Million
-14,495 Reduced 0.72%
1,994,418 $402 Million
Q1 2021

May 14, 2021
SELL
$207.02 - $241.31 $20.6 Million - $24 Million
-99,555 Reduced 4.72%
2,008,913 $432 Million
Q4 2020

Feb 02, 2021
SELL
$207.01 - $276.09 $10.9 Million - $14.6 Million
-52,776 Reduced 2.44%
2,108,468 $498 Million
Q3 2020

Nov 05, 2020
SELL
$255.65 - $303.1 $4.62 Million - $5.48 Million
-18,080 Reduced 0.83%
2,161,244 $588 Million
Q2 2020

Aug 12, 2020
BUY
$225.48 - $295.8 $360 Million - $472 Million
1,596,444 Added 273.89%
2,179,324 $633 Million
Q1 2020

May 12, 2020
SELL
$199.77 - $247.81 $4.61 Million - $5.72 Million
-23,089 Reduced 3.81%
582,880 $139 Million
Q4 2019

Jan 27, 2020
BUY
$166.71 - $223.91 $10.1 Million - $13.6 Million
60,781 Added 11.15%
605,969 $133 Million
Q3 2019

Oct 31, 2019
BUY
$166.23 - $187.09 $25.6 Million - $28.8 Million
153,979 Added 39.36%
545,188 $92.4 Million
Q2 2019

Aug 15, 2019
SELL
$164.61 - $190.37 $1.78 Million - $2.06 Million
-10,796 Reduced 2.69%
391,209 $71.7 Million
Q1 2019

May 03, 2019
SELL
$163.73 - $194.7 $1.29 Million - $1.54 Million
-7,903 Reduced 1.93%
402,005 $73.9 Million
Q4 2018

Feb 08, 2019
SELL
$151.91 - $192.21 $4.75 Million - $6.01 Million
-31,292 Reduced 7.09%
409,908 $67.9 Million
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $5.95 Million - $6.83 Million
-35,455 Reduced 7.44%
441,200 $85 Million
Q2 2018

Aug 15, 2018
SELL
$145.72 - $169.96 $8.85 Million - $10.3 Million
-60,706 Reduced 11.3%
476,655 $81 Million
Q1 2018

May 11, 2018
SELL
$151.6 - $177.13 $6.95 Million - $8.13 Million
-45,876 Reduced 7.87%
537,361 $87.6 Million
Q4 2017

Feb 06, 2018
BUY
$137.28 - $155.55 $9.89 Million - $11.2 Million
72,019 Added 14.09%
583,237 $87.4 Million
Q3 2017

Nov 15, 2017
BUY
$148.13 - $162.24 $75.7 Million - $82.9 Million
511,218
511,218 $77.7 Million

Others Institutions Holding VRTX

# of Institutions
1,761
Shares Held
228M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email